Acadian Asset Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-155,572
Closed -$295K 1670
2023
Q4
$295K Buy
155,572
+27,273
+21% +$40.7K ﹤0.01% 1151
2023
Q3
$168K Buy
+128,299
New +$282K ﹤0.01% 1225
2022
Q2
Sell
-4,023
Closed -$65K 1760
2022
Q1
$65K Buy
+4,023
New +$103K ﹤0.01% 1435
2021
Q4
Sell
-42,214
Closed -$3.06M 1759
2021
Q3
$3.06M Sell
42,214
-172,360
-80% -$12.5M 0.01% 570
2021
Q2
$18M Buy
+214,574
New +$14.2M 0.07% 230

Other funds holding NBP

Acadian Asset Management's NBP Position: Q1 2024 in Review

Acadian Asset Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2024, closing a stake of 155,572 shares — an estimated $295K sold.

Acadian Asset Management first reported a position in NBP in Q2 2021 and held it in 5 quarters. The position peaked at $18M in Q2 2021. 39 funds tracked by Wall St. Rank hold NBP as of Q1 2024.

  • Acadian Asset Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2024 after selling out during the quarter.
  • Acadian Asset Management sold 155,572 NovaBridge Biosciences American Depositary Shares shares in Q1 2024, an estimated $295K.
  • Acadian Asset Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q2 2021 and held it in 5 quarters.
  • Acadian Asset Management's NovaBridge Biosciences American Depositary Shares position peaked at $18M in Q2 2021.
  • 39 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2024.

Based on Acadian Asset Management's 13F filing for Q1 2024, filed 10 May 2024.